Market Access News | pharmaphorum

News

George Medicines chief executive Mark Mallon

George gets FDA nod for first blood pressure triple therapy

George Medicines' Widaplik can address key challenges in current hypertension treatment, according to the UK drugmaker's CEO.

News

Sanofi starts shipping RSV drug early as rival nears market

As an FDA decision nears from a rival MSD drug, Sanofi is speeding up the rollout of RSV antibody Beyfortus to get ahead of this year's season.

News

AZ claims EU approval for new Calquence regimens in CLL

AstraZeneca has secured a key approval for its BTK inhibitor Calquence in Europe, currently facing a strong challenge from BeOne's rival Brukinsa.

News

Wockhardt has high hopes for novel antibiotic Zaynich

Wockhardt has completed a pre-filing meeting with the FDA and is preparing to submit its novel antibiotic Zaynich in the US and Europe.

News

NHS cleared to use Novo Nordisk's long-acting growth hormone

Novo Nordisk's long-acting injectable Sogroya has been backed for NHS use in young people with growth hormone deficiency.

News

Ascletis says oral acne drug shows "exceptional efficacy"

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US.

George gets FDA nod for first blood pressure triple therapy

Sanofi starts shipping RSV drug early as rival nears market

AZ claims EU approval for new Calquence regimens in CLL

Wockhardt has high hopes for novel antibiotic Zaynich

NHS cleared to use Novo Nordisk's long-acting growth hormone

Ascletis says oral acne drug shows "exceptional efficacy"

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks